Exact FDA event identifier

Event 98687

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: March 25, 2026
Product types: Drug
Classifications: Class II
Statuses: Ongoing
Recalling firm wording: Preferred Pharmaceuticals, Inc.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0

D-0443-2026

Recall number: D-0443-2026
Initiated: March 25, 2026
Classification: Class II
Status: Ongoing
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 720 bottles

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility

Code information

Lot #: F1924R, F2024G, F2424E, G2424M, G2624P, J2424M

Distribution pattern

Nationwide within the United States